Jpmorgan Chase & CO Kezar Life Sciences, Inc. Transaction History

Jpmorgan Chase & CO

$1.22 Trillion
Q3 2024

A detailed history of Jpmorgan Chase & CO transactions in Kezar Life Sciences, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 1,665 shares of KZR stock, worth $12,321. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,665

Previous 3,187 47.76%

Holding current value

$12,321

Previous $1,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$0.53 - $0.77 $806 - $1,171	-1,522 Reduced 47.76%	1,665 $1,000
Q2 2024 Aug 12, 2024	SELL	$0.6 - $0.92 $16,366 - $25,094	-27,277 Reduced 89.54%	3,187 $1,000
Q1 2024 May 10, 2024	SELL	$0.8 - $1.05 $12,636 - $16,584	-15,795 Reduced 34.14%	30,464 $27,000
Q4 2023 Feb 12, 2024	SELL	$0.72 - $1.15 $656,900 - $1.05 Million	-912,362 Reduced 95.17%	46,259 $43,000
Q3 2023 Nov 14, 2023	SELL	$1.08 - $2.54 $130,744 - $307,492	-121,060 Reduced 11.21%	958,621 $1.14 Million
Q2 2023 Aug 11, 2023	SELL	$2.31 - $3.06 $17,576 - $23,283	-7,609 Reduced 0.7%	1,079,681 $2.65 Million
Q1 2023 May 18, 2023	BUY	$3.13 - $7.31 $126,217 - $294,775	40,325 Added 3.85%	1,087,290 $3.4 Million
Q1 2023 May 11, 2023	SELL	$3.13 - $7.31 $74,810 - $174,716	-23,901 Reduced 2.23%	1,046,965 $3.28 Million
Q4 2022 Feb 13, 2023	BUY	$6.39 - $8.8 $83,824 - $115,438	13,118 Added 1.24%	1,070,866 $7.54 Million
Q3 2022 Nov 14, 2022	SELL	$7.99 - $10.75 $349,866 - $470,721	-43,788 Reduced 3.98%	1,057,748 $9.11 Million
Q2 2022 Aug 11, 2022	BUY	$4.58 - $17.13 $4.75 Million - $17.8 Million	1,037,748 Added 1626.87%	1,101,536 $9.11 Million
Q1 2022 May 11, 2022	BUY	$12.3 - $18.33 $569,182 - $848,220	46,275 Added 264.23%	63,788 $1.06 Million
Q4 2021 Feb 10, 2022	BUY	$7.44 - $16.72 $6,651 - $14,947	894 Added 5.38%	17,513 $293,000
Q3 2021 Nov 12, 2021	BUY	$4.85 - $9.73 $80,602 - $161,702	16,619 New	16,619 $144,000

Others Institutions Holding KZR

# of Institutions

Shares Held

38.4M

Call Options Held

13.8K

Put Options Held

600

View Full List

About Kezar Life Sciences, Inc.

Ticker KZR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,369,504
Market Cap $506M
Description
Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical tria...

More about KZR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Kezar Life Sciences, Inc. Transaction History